OPKO Health Inc (NASDAQ:OPK) Q2 2025 Earnings Miss Estimates, Stock Plunges 7.8% OPKO Health's Q2 2025 earnings missed revenue and EPS estimates, causing a 7.8% stock drop. Weak performance in pharma/diagnostics segments and higher losses raised investor concerns.
This Nano-Cap E-Commerce Play Saw 3,100% Jump In Retail Chatter Last Week: What's Behind The Surge? Late Friday, the company said the U.S.-China tariffs will have a material impact on anticipated sales of U.S. products into China.
Opko Health (OPK) Q4 2024 Earnings Call Transcript OPK earnings call for the period ending December 31, 2024.
3 Stocks That Wall Street Insiders Can’t Stop Buying Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.
Opko Health (OPK) Q3 2024 Earnings Call Transcript OPK earnings call for the period ending September 30, 2024.
Opko Health Stock Is Climbing: What's Going On? Opko Health shares are trading higher Thursday after the company announced a $100 million share repurchase program. Here's a look at what to know:
Why Opko Health Shares Are Up After-Hours Opko Health shares are trading higher after-hours Wednesday. The company announced it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx).
The 2024 Millionaire’s Club: 3 Penny Stocks to Buy Now One of the best ways to spot opportunity in penny stocks to buy is by following insiders. Here are three to consider.
